SCHEMBL20207904

SCHEMBL20207904

c1ccc(-n2c3ccccc3c3cc(-c4ccc5cc(-c6c7ccccc7nc7c6ccc6cccnc67)ccc5c4)ccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ATM Q13315 1/20 0.38
▸ PTGER4 P35408 1/20 0.35
▸ ESR1 P03372 4/20 0.34
▸ ESR2 Q92731 4/20 0.34
▸ LMNA P02545 2/20 0.34
▸ TOP1 P11387 4/20 0.33
▸ MTOR P42345 2/20 0.33
▸ TSHR P16473 2/20 0.33
▸ CCR1 P32246 2/20 0.33
▸ CCR5 P51681 2/20 0.33
▸ CCR8 P51685 2/20 0.33
▸ GMNN O75496 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ MMP2 P08253 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21308695 0.98 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4ESR1
SCHEMBL21308991 0.97 L3MBTL1 (0.40) KDM4EL3MBTL1ATMPTGER4ESR1
SCHEMBL20207903 0.96 KDM4E (0.38) KDM4EL3MBTL1ATMPTGER4ESR1
SCHEMBL20207912 0.95 KDM4E (0.37) KDM4EL3MBTL1ATMPTGER4ESR1
SCHEMBL21308465 0.95 KDM4E (0.38) KDM4EL3MBTL1ATMPTGER4ESR1
SCHEMBL20208137 0.93 ESR1 (0.36) KDM4EL3MBTL1ATMESR1ESR2
SCHEMBL20207943 0.91 MTOR (0.33) KDM4EL3MBTL1ATMESR1ESR2
SCHEMBL20207944 0.91 KDM4E (0.37) KDM4EL3MBTL1ATMPTGER4LMNA
SCHEMBL20208414 0.91 ESR1 (0.36) KDM4EL3MBTL1ATMPTGER4ESR1
SCHEMBL21309010 0.90 ESR1 (0.36) KDM4EL3MBTL1ATMPTGER4ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11248008-B2 Heterocyclic compound and organic light emitting element using same LT MATERIALS CO., LTD. (KR) 2022-02-15 — — US disclosed
US-20190263834-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2019-08-29 — — US disclosed
WO-2018097648-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME 희성소재(주) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190263834-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, CYP1A1 KDM4E 3716/4885L3MBTL1 2715/4885ATM 3942/4885
US-11248008-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, CYP1A1 KDM4E 3716/4885L3MBTL1 2715/4885ATM 3942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback